NCT05898828 2024-08-05Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal CancerNational Institutes of Health Clinical Center (CC)Phase 1/2 Withdrawn